Kongsberg Beam Technology appoints Stephan Dymling as new Chief Technology Officer


Stephan Dymling has been appointed new Chief Technology Officer of Kongsberg Beam Technology.

Stephan joins Kongsberg Beam Technology with extensive experience, both nationally and internationally from the medical device industry. For the past eleven years he has served as CTO for Clinical Laserthermia Systems, a MedTech company developing more precise treatment tools for laser ablation of diseased tissue such as tumours, based in Sweden. During this period, he has also in parallel been part of the management and one of the founders of the biopsy company BiBB Instruments AB. Prior to that Stephan Dymling held positions as Chief Technical Officer and R&D Manager at Epsilon Embedded Systems, Medical Vision AB, SpectraCure AB and ProstaLund Operations AB.

Stephan Dymling holds a PhD in biomedical engineering from Lund University, Lund Institute of Technology in Sweden.

“I’m looking forward to joining Kongsberg Beam Technology, a next generation company in radiation therapy, and together with the team continue developing the MaMa-K ™ system for improved cancer treatment. The company is in an interesting phase of developing its product and I believe my experience will contribute to further advancements in our technology” says Stephan Dymling.

“We are happy to welcome Stephan Dymling to Kongsberg Beam Technology. Stephan will be a great addition to the team and with his strong set of values and his ability to execute on growth strategies, he will be vital in bringing Kongsberg Beam Technology to the next level”, says Kerstin Jakobsson, CEO.

Stephan Dymling succeeds Per Håvard Kleven who will continue being instrumental for Kongsberg Beam Technology focusing on Special projects and patents.

Download Press Release as pdf

For further information please contact:
Kerstin Jakobsson
CEO, Kongsberg Beam Technology AS
Phone: +46 705 50 45 40

About Kongsberg Beam Technology
Kongsberg Beam Technology is a MedTech company preventing radiation of healthy tissue in oncology applications by the innovative solution, MaMa-K™ which is applicable both in traditional radiation therapy and proton therapy. The technology of MaMa-K is based on a digital twin of the patient with motion tracking in real-time to create a more efficient radiation treatment with less damage of healthy tissue. Kongsberg Beam Technology is headquartered in Kongsberg, Norway. For more information, please visit www.kongsbergbeamtech.com.